HTA and Value-Based Healthcare: Methods Part 2


HTA and Value-Based Healthcare: Methods

March 25, 2021
8:00 a.m. MDT


Richard Charter, Vice-President, Alira Health

Andrea Rappagliosi, Vice President Market Access, Public Affairs & Communication EMEA, Canada and LATAM
Edwards Lifesciences
Joseph Casey – Director of Partnerships and Programme

Session Details:

This session will build on the methods discussed in the first session through a series of case studies. Using real-life experiences, the speakers will distinguish the roles of HTA and Value-Based Healthcare in the evaluation and implementation of medical technologies and discuss value-based access programs (managed entry agreements). This session aims to give participants an understanding of how to implement the different methods in practice and will discuss how they complement each other in a rapidly evolving MedTech landscape.